Showing results (11-20 of 215) with videos related to
Sort By:
Pageof 22
European Journal of Immunology|July 4, 2015
A constant threat for HIV: Fc-engineering to enhance broadly neutralizing antibody activity for immunotherapy of the acquired immunodeficiency syndromeFalk NimmerjahnSpringer Seminars in Immunopathology|November 23, 2006
Activating and inhibitory FcgammaRs in autoimmune disordersFalk NimmerjahnHandbook of Experimental Pharmacology|March 22, 2025
Role of Antibody Glycosylation in Health, Disease, and TherapyFalk NimmerjahnJournal of Clinical Immunology|March 10, 2016
Translating Inhibitory Fc Receptor Biology into Novel Therapeutic ApproachesFalk NimmerjahnCell Reports|April 2, 2014
A humanized mouse identifies the bone marrow as a niche with low therapeutic IgG activityAnja Lux, Michaela Seeling, Anne Baerenwaldt, et al.Glycobiology|August 29, 2022
Response to Oswald et al.: ST6Gal1 in plasma is dispensable for IgG sialylationAnja Werner, Falk NimmerjahnImmunology Letters|January 31, 2012
Low level of FcγRIII expression on murine natural killer cellsMarkus Biburger, Falk NimmerjahnCancer Cell|January 14, 2015
No need for constant help: human IgG2 antibodies have an autonomous agonistic activity for immunotherapy of cancerAnja Lux, Falk NimmerjahnPageof 22